| Date | Name/CAS No. | Suppliers/Manufactures | Check | ||
|---|---|---|---|---|---|
| 04-15 09:56 | Larcaviximab 1792982-56-9 |
||||
| 04-15 09:56 | Oleclumab 1803176-05-7 |
||||
| 04-15 09:56 | Tomuzotuximab 1646321-00-7 |
||||
| 04-15 09:56 | Maftivimab 2135632-36-7 |
||||
| 04-15 09:56 | Garetosmab 2097125-54-5 |
||||
| 04-15 09:56 | Flotetuzumab 1664355-28-5 |
||||
| 04-15 09:56 | Losatuxizumab 1801544-27-3 |
||||
| 04-15 09:56 | Varisacumab 1610010-60-0 |
||||
| 04-15 09:56 | Lacnotuzumab 1831128-32-5 |
||||
| 04-15 09:56 | Selicrelumab 1622140-49-1 |
||||
| 04-15 09:56 | Azintuxizumab 1826819-57-1 |
||||
| 04-15 09:56 | Gedivumab 1807954-17-1 |
||||
| 04-15 09:56 | Lesofavumab 1807960-57-1 |
||||
| 04-15 09:56 | Ranevetmab 1632282-27-9 |
||||
| 04-15 09:56 | Brazikumab 1610353-18-8 |
||||
| 04-15 09:56 | Emapalumab 1709815-23-5 |
||||
| 04-15 09:56 | Crizanlizumab 1690318-25-2 |
||||
| 04-15 09:56 | Ravulizumab 1803171-55-2 |
||||
| 04-15 09:56 | Tomaralimab 1449294-76-1 |
||||
| 04-15 09:56 | Lupartumab 1640971-88-5 |